These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21904634)

  • 1. NVC-422 topical gel for the treatment of impetigo.
    Iovino SM; Krantz KD; Blanco DM; Fernández JA; Ocampo N; Najafi A; Memarzadeh B; Celeri C; Debabov D; Khosrovi B; Anderson M
    Int J Clin Exp Pathol; 2011 Aug; 4(6):587-95. PubMed ID: 21904634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
    Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
    Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
    Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C
    J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.
    Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM
    Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
    Oranje AP; Chosidow O; Sacchidanand S; Todd G; Singh K; Scangarella N; Shawar R; Twynholm M;
    Dermatology; 2007; 215(4):331-40. PubMed ID: 17911992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current options for the treatment of impetigo in children.
    Sladden MJ; Johnston GA
    Expert Opin Pharmacother; 2005 Oct; 6(13):2245-56. PubMed ID: 16218885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
    Gisby J; Bryant J
    Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microbiology of impetigo in indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage.
    Bowen AC; Tong SY; Chatfield MD; Carapetis JR
    BMC Infect Dis; 2014 Dec; 14():727. PubMed ID: 25551178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
    Liu Y; Kong F; Zhang X; Brown M; Ma L; Yang Y
    Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.
    Jacobs MR
    Future Microbiol; 2007 Dec; 2(6):591-600. PubMed ID: 18041900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
    Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF
    Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli.
    D'Lima L; Friedman L; Wang L; Xu P; Anderson M; Debabov D
    Antimicrob Agents Chemother; 2012 May; 56(5):2753-5. PubMed ID: 22354299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial.
    Rosen T; Albareda N; Rosenberg N; Alonso FG; Roth S; Zsolt I; Hebert AA
    JAMA Dermatol; 2018 Jul; 154(7):806-813. PubMed ID: 29898217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impetigo - review.
    Pereira LB
    An Bras Dermatol; 2014; 89(2):293-9. PubMed ID: 24770507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impetigo: diagnosis and treatment.
    Hartman-Adams H; Banvard C; Juckett G
    Am Fam Physician; 2014 Aug; 90(4):229-35. PubMed ID: 25250996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Ozenoxacin Cream 1% for Impetigo: A Review.
    Schachner L; Andriessen A; Bhatia N; Grada A; Patele D
    J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impetigo update: new challenges in the era of methicillin resistance.
    Geria AN; Schwartz RA
    Cutis; 2010 Feb; 85(2):65-70. PubMed ID: 20349679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.
    Yang LP; Keam SJ
    Drugs; 2008; 68(6):855-73. PubMed ID: 18416589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.
    Vogel A; Lennon D; Best E; Leversha A
    N Z Med J; 2016 Oct; 129(1443):77-83. PubMed ID: 27736855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ozenoxacin: A Novel Topical Quinolone for Impetigo.
    Wren C; Bell E; Eiland LS
    Ann Pharmacother; 2018 Dec; 52(12):1233-1237. PubMed ID: 29962213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.